A surge in other income and a decline in provisions support NAVI's Q3 2024 results. Lower NII and higher expenses are headwinds.
Although the revenue and EPS for Navient (NAVI) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Navient (NAVI) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.84 per share a year ago.
Lower fee income is likely to hurt NAVI's Q3 2024 results. A sequential increase in NII and cost control measures are set to offer support.
Navient (NAVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NAVI to divest its healthcare services business Xtend to CorroHealth. Over 925 Xtend employees join the CorroHealth team as part of the deal.
Investors need to pay close attention to Navient (NAVI) stock based on the movements in the options market lately.
The CFPB issues an order against NAVI to permanently ban it from servicing federal direct loans. Navient needs to pay $120 million to settle the CFPB's claims.
Navient is exiting the federal student loan business as a regulator prepares to fine it $120 million. The company, formerly known as Sallie Mae, was sued in 2017 by the Consumer Financial Protection Bureau (CFPB) over its lending practices.
In 2017, the Consumer Financial Protection Bureau sued Navient regarding its student-loan practices.
The settlement resolves a lawsuit filed by the Consumer Financial Protection Bureau in 2017, which claimed the company led borrowers astray.
Navient reaches $120 million settlement with CFPB for misleading student loan borrowers